A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma
Condition(s):Relapsed Multiple Myeloma; Refractory Multiple MyelomaLast Updated:March 9, 2022Completed